Solaris Endovascular Inc.
Dallas, TX ยท Biotechnology
Solaris Endovascular Inc. is a biotechnology company based in Dallas, Texas. In a Form D filed with the SEC on October 1, 2026, it reported raising $4,972,500 from 45 investors as part of an offering of up to $10,000,000. The first sale in the offering took place on September 5, 2025.
- Website
- solarisendovascular.com
- Amount raised
- $4,972,500
- Offering size
- $10,000,000
- Investors so far
- 45
- Minimum investment
- $2,500
- First sale
- September 5, 2025
- Securities offered
- Equity, Debt, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Dallas, Texas
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $4,972,500 | $10,000,000 | 45 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Texas
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| FibroBiologics, Inc. | Houston, TX | Health Care | $1.2M | $1.2M | |
| Lucier Pharmaceuticals Inc. | Bryan, TX | Health Care | โ | $2M | |
| Surgical Caregivers of Fort Worth, LLC | Fort Worth, TX | Health Care | โ | $498K | |
| TMF1 Akido, LLC | Houston, TX | Health Care | โ | $1M | |
| OncoNano Medicine, Inc. | Dallas, TX | Health Care | $10.1M | $15M | |
| Pressio, Inc. | San Antonio, TX | Health Care | $544K | $6M |